AI in Drug Discovery USA 2026
The AI Drug Discovery Development Summit (AIDDD) 2026 gathers 1,000+ attendees and 200+ speakers in Boston (Oct 27‑29) to showcase AI across the pharmaceutical pipeline. Six dedicated tracks—HPC & AI Infrastructure, Biology, Chemistry, Clinical Trials, Tech Ops, and Data Management—address every stage from target identification to trial analytics. The program features senior leaders from Novo Nordisk, Isomorphic Labs, Recursion, Insitro, Astellas, Regeneron, Eli Lilly, MindWalk, Takeda, Pfizer, AstraZeneca, and others, highlighting breakthroughs such as HYFT® explainable AI for biology. Exhibitors and partners span AI‑tech vendors, CROs, biotech firms, pharma giants, investors, and academic institutions, with a robust sponsor ecosystem (lead, track, gold, silver, bronze partners). Attendees gain actionable insights, benchmark AI strategies, network with decision‑makers, and explore data‑challenge workshops, positioning the summit as a central hub for AI‑driven drug discovery and development.
Регистрация для входа или кабины
Карта мест и отели вокруг
Бостон - Courtyard by Marriott Boston Downtown, Массачусетс, США